Literature DB >> 15981676

Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.

Hideaki Matsui1, Fukashi Udaka, Masaya Oda, Akiko Tamura, Tamotsu Kubori, Kazuto Nishinaka, Masakuni Kameyama.   

Abstract

BACKGROUND: Decreased cardiac metaiodobenzylguanidine (MIBG) uptake was reported in Parkinson's disease and this contributes to the differential diagnosis between Parkinson's disease and other forms of parkinsonism such as multiple system atrophy. However, decreased MIBG uptake of the thyroid has not been demonstrated.
OBJECTIVE: To compare MIBG uptake of the thyroid among Parkinson's disease, multiple system atrophy and controls.
METHODS: Twenty-six patients with Parkinson's disease, 11 patients with multiple system atrophy and 14 controls were examined in this study. Planar images were taken 15 minutes (early images) and 3 hours (late images) after intravenous injection of 111 MBq 123I-MIBG.
RESULTS: MIBG uptake of the thyroid on early images decreased significantly in Parkinson's disease compared to controls (p < 0.0001) and multiple system atrophy (p = 0.018). MIBG uptake of the thyroid on early images decreased significantly also in multiple system atrophy compared to controls (p = 0.027). On late images, thyroid uptake differed significantly only between Parkinson's disease and controls (p = 0.010).
CONCLUSIONS: Our study is the first to demonstrate decreased MIBG uptake of the thyroid in Parkinson's disease. Sympathetic nervous denervation of Parkinson's disease occurred not only in the heart but also in the thyroid.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981676     DOI: 10.1007/BF02984609

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  11 in total

1.  Central dopamine deficiency in pure autonomic failure.

Authors:  David S Goldstein; Courtney Holmes; Takuya Sato; Miya Bernson; Neptune Mizrahi; Richard Imrich; Gilberto Carmona; Yehonatan Sharabi; Alexander O Vortmeyer
Journal:  Clin Auton Res       Date:  2008-04       Impact factor: 4.435

2.  May the thyroid gland and thyroperoxidase participate in nitrosylation of serum proteins and sporadic Parkinson's disease?

Authors:  Emilio Fernández; José-Manuel García-Moreno; Angel Martín de Pablos; José Chacón
Journal:  Antioxid Redox Signal       Date:  2014-09-30       Impact factor: 8.401

3.  1-23I-MIBG thyroid uptake: Implications for MIBG imaging of the heart.

Authors:  Raffaele Giubbini; Elisa Milan; Claudio Marcassa; Barbara Paghera; Federica Fracassi; Luca Camoni; Carlo Rodella; Francesco Bertagna; Federica Motta; Mattia Bertoli; Riccardo Campini
Journal:  J Nucl Cardiol       Date:  2015-05-13       Impact factor: 5.952

4.  Thyroid hormone level is associated with motor symptoms in de novo Parkinson's disease.

Authors:  Tadashi Umehara; Hiromasa Matsuno; Chizuko Toyoda; Hisayoshi Oka
Journal:  J Neurol       Date:  2015-05-19       Impact factor: 4.849

5.  Generalized and neurotransmitter-selective noradrenergic denervation in Parkinson's disease with orthostatic hypotension.

Authors:  Yehonatan Sharabi; Richard Imrich; Courtney Holmes; Sandra Pechnik; David S Goldstein
Journal:  Mov Disord       Date:  2008-09-15       Impact factor: 10.338

6.  Thyroid MIBG uptake in Parkinson's disease with diabetes mellitus.

Authors:  Wooyoung Jang; Joong-Seok Kim; Jin Whan Cho; Jin Young Ahn; Yun Young Choi; Hee-Tae Kim
Journal:  Clin Auton Res       Date:  2013-07-11       Impact factor: 4.435

Review 7.  Imaging Systemic Dysfunction in Parkinson's Disease.

Authors:  Per Borghammer; Karoline Knudsen; David J Brooks
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

8.  Imaging Parkinson's disease below the neck.

Authors:  Per Borghammer; Karoline Knudsen; Tatyana D Fedorova; David J Brooks
Journal:  NPJ Parkinsons Dis       Date:  2017-04-25

9.  Cardiac sympathetic innervation and vesicular storage in pure autonomic failure.

Authors:  David S Goldstein; Risa Isonaka; Courtney Holmes; Yu-Shin Ding; Yehonatan Sharabi
Journal:  Ann Clin Transl Neurol       Date:  2020-09-10       Impact factor: 4.511

Review 10.  Catecholamines and Neurodegeneration in Parkinson's Disease-From Diagnostic Marker to Aggregations of α-Synuclein.

Authors:  Hideyuki Sawada; Tomoko Oeda; Kenji Yamamoto
Journal:  Diagnostics (Basel)       Date:  2013-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.